# Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height

> **NCT00174421** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 36 (—)

## Conditions studied

- Growth Disorder

## Interventions

- **DRUG:** Treatment with Genotropin in different dosages

## Key facts

- **NCT ID:** NCT00174421
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-04
- **Primary completion:** —
- **Final completion:** 2005-08
- **Target enrollment:** 36 (—)
- **Last updated:** 2007-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00174421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00174421, "Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height". Retrieved via MORVS 2026-11-19 from https://api.morvs.ai/clinical/NCT00174421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
